You are here

Home / Resources / Key Material
Export 533 results:
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
U
US Food and Drug Administration (2005).  Foodborne pathogenic microorganisms and natural toxins handbook—Staphylococcus aureus.
United, EPA. (2004).  Air Quality Criteria for Particulate Matter.
International Triathlon Union (2012).  ITU Competition Rules.
Ungar, B.. L., Burris J.. A., Quinn C.. A., & Finkelman F.. D. (1990).  New mouse models for chronic Cryptosporidium infection in immunodeficient hosts. Infection and Immunity. 58, 4.
Ungar, B.. L. P., Soave R.., Fayer R.., & Nash T.. E. (1986).  Enzyme Immunoassay Detection of Immunoglobulin M and G Antibodies to Cryptosporidium in Immunocompetent and Immunocompromised Persons. Journal of Infectious Diseases. 153, 570-578.
T
Tunney, C. (2017).  Newspaper Coverage of the Flint Water Crisis: An Empirical Analysis to Support a New Model for Latent Environmental Disasters.
M. Trivendi, P. M. (2011).  Severe Acute Respiratory Syndrome (SARS). 12, 1-31.
Tribble, D.. R., Baqar S.., Carmolli M.. P., Porter C.., Pierce K.. K., Sadigh K.., et al. (2009).  Campylobacter jejuni strain CG8421: a refined model for the study of Campylobacteriosis and evaluation of Campylobacter vaccines in human subjects. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. 49, 1512-1519.
Tribble, D. R., Baqar S., Scott D. A., Oplinger M. L., Trespalacios F., Rollins D., et al. (2010).  Assessment of the Duration of Protection in Campylobacter jejuni Experimental Infection in Humans. Infection and Immunity. 78, 4.
Tribble, D. R., Baqar S., Carmolli M. P., Porter C., Pierce K. K., Sadigh K., et al. (2009).  Campylobacter jejuni Strain CG8421: A Refined Model for the Study of Campylobacteriosis and Evaluation of Campylobacter Vaccines in Human Subjects. Clinical Infectious Diseases. 49, 10.
Tribble, D. R., Baqar S., Carmolli M. P., Porter C., Pierce K. K., Sadigh K., et al. (2009).  Campylobacter jejuni strain CG8421: a refined model for the study of Campylobacteriosis and evaluation of Campylobacter vaccines in human subjects. Clinical infectious diseases. 49, 1512–1519.
Titball, R. W., & Sjostedt A. (2003).  Francisella tularensis: an overview. American Society for Microbiology News. 69, 558-563.
Thomas, V., McDonnell G., Denyer S. P., & Maillard J-Y. (2010).  Free-living amoebae and their intracellular pathogenic microorganisms: risks for water quality. FEMS microbiology reviews. 34, 231–259.
Teunis, PFM., Medema GJ., Kruidenier L., & Havelaar AH. (1997).  Assessment of the risk of infection by Cryptosporidium or Giardia in drinking water from a surface water source. Water Research. 31, 1333–1346.
Teunis, P. F. M., Nagelkerke N. J. D., & Haas C. N. (1999).  Dose response models for infectious gastroenteritis. Risk Analysis. 19, 1251–1260.
Teunis, P.., Takumi K.., & Shinagawa K.. (2004).  Dose response for infection by Escherichia coli O157:H7 from outbreak data. Risk Analysis: An Official Publication of the Society for Risk Analysis. 24, 401-407.
Ternhag, A.., Asikainen T.., Giesecke J.., & Ekdahl K.. (2007).  A Meta-Analysis on the Effects of Antibiotic Treatment on Duration of Symptoms Caused by Infection with Campylobacter Species. Clinical Infectious Diseases. 44, 5.
Taylor-Robinson, D.., & Bynoe M.. L. (1963).  Para-influenza 2 virus infections in adult volunteers. The Journal of Hygiene. 61, 4.
Taylor, D. M., Woodgate S. L., & Atkinson M. J. (1995).  Inactivation of the bovine spongiform encephalopathy agent by rendering procedures. Veterinary Record. 137(24), 
Tärnvik, A.., & Berglund L.. (2003).  Tularaemia. European Respiratory Journal. 21, 2.
Tansey, J., & O'riordan T. (1999).  Cultural theory and risk: a review. Health, risk & society. 1, 71-90.
Tamrakar, S. B., Haluska A., Haas C. N., & Bartrand B. A. (2011).  Dose-Response Model of Coxiella burnetii (Q Fever). Risk Analysis. 31, 120-128.
Tamrakar, S. B., Haluska A., Haas C. N., & Bartrand T. A. (2011).  Dose-Response Model of Coxiella burnetii (Q Fever). Risk Analysis. 31, 120–128.
Tacket, C. O., Sztein M. B., Losonsky G., Abe A., Finlay B. B., McNamara B. P., et al. (2000).  Role of EspB in Experimental Human Enteropathogenic Escherichia coli Infection. Infection and Immunity. 68, 6.
S
Sur, D., & (2004).  Shigellosis: challenges & management issues. Indian Journal of Medical Research. 120, 5.